Genelux Corp (GNLX) Stock Price, Quote, News & History

GNLXNASDAQ
$2.44
-0.08-3.17%
At close: Sep 4, 5:00 PM EST
$2.63
0.197.94%
After Hours: 7:51 PM EST

Genelux (GNLX) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
$2.52
Close
$2.44
Volume / Avg.
296.53K / 251.75K
Day Range
$2.42 - $2.54
52 Wk Range
2.29 - 8.54
Market Cap
$119.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
46
Short Interest
8.01%
Days to Cover
8.45

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.28M
Investing Cash Flow (TTM)
8.71M
Financing Cash Flow (TTM)
19.20M
Free Cash Flow (TTM)
-28.68M
Capital Expenditure (TTM)
-3.41M
Net Change in Cash (TTM)
2.64M

Analyst Trends and Forecast

0
0
0
0
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$97.77M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
13003.89
PB Ratio (TTM)
7.08
Earnings Yield % (TTM)
-34.13%
Earnings Yield % (FWD)
-23.41%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.36

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$9.18M
Debt to Equity
0.15
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.52
Close
$2.44
Volume / Avg.
296.53K / 251.75K
Day Range
$2.42 - $2.54
52 Wk Range
2.29 - 8.54
Market Cap
$119.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
46
Short Interest
8.01%
Days to Cover
8.45

About

Sector
Health Care
Industry
Biotechnology
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tu...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Genelux (GNLX) stock?

A

You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Genelux (GNLX) stock?

A

Genelux has a consensus price target of $19.63.

Q

What is the current price for Genelux (GNLX)?

A

The stock price for Genelux (NASDAQ: GNLX) is $2.6338 last updated September 4, 2026 at 7:51 PM EDT.

Q

Does Genelux (GNLX) pay a dividend?

A

There are no upcoming dividends for Genelux.

Q

When is Genelux (NASDAQ:GNLX) reporting earnings?

A

Genelux does not have any upcoming earnings scheduled.

Q

Is Genelux (GNLX) going to split?

A

There is no upcoming split for Genelux.

Q

What sector and industry does Genelux (GNLX) operate in?

A

Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.